Brief: Following Complete Clearance of Cancer Lesions in Advanced Liver Cancer Patient, Can-Fite is Filing Patent Applications for the Treatment of Various Advanced Solid Tumors
29/12/2021 12:04
Dec 29 (Reuters) - Can Fite Biopharma Ltd CANF.TA :
* FOLLOWING COMPLETE CLEARANCE OF CANCER LESIONS IN ADVANCED
LIVER
CANCER PATIENT, CAN-FITE IS FILING PATENT APPLICATIONS FOR THE
TREATMENT OF VARIOUS ADVANCED SOLID TUMORS
* CAN FITE BIOPHARMA LTD - NAMODENOSON HEADED INTO PIVOTAL
PHASE
III LIVER CANCER STUDY
Source text for Eikon: ID:nBw92r0Xsa
Further company coverage: CANF.TA
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Can Fite Biopharma
See all newsBrief: Corrected-Can Fite Biopharma Ltd Files For Offering Of Up To 6.6 mln Ordinary Shares By Selling Shareholders
Can-Fite BioPharma rises after longer-than-anticipated overall survival in ongoing liver cancer study
Can-Fite BioPharma reports longer-than-anticipated overall survival in ongoing liver cancer study
Brief: Can Fite Biopharma Can-Fite Submits Phase 2 Study Protocol For Piclidenoson In Lowe Syndrome
Can-Fite rises as skin drug study reaches interim analysis stage